Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fracture Fixation, Internal | 8 | 2026 | 128 | 2.670 |
Why?
|
| Fractures, Bone | 7 | 2025 | 144 | 1.900 |
Why?
|
| Fractures, Ununited | 2 | 2025 | 23 | 1.480 |
Why?
|
| Fracture Healing | 3 | 2019 | 44 | 1.280 |
Why?
|
| Pelvic Bones | 2 | 2020 | 29 | 1.170 |
Why?
|
| Femoral Neck Fractures | 2 | 2019 | 15 | 1.160 |
Why?
|
| Orthopedic Procedures | 3 | 2022 | 89 | 1.030 |
Why?
|
| Bone Screws | 4 | 2025 | 56 | 0.960 |
Why?
|
| Manubrium | 1 | 2025 | 2 | 0.930 |
Why?
|
| Sternum | 1 | 2025 | 14 | 0.920 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2018 | 65 | 0.810 |
Why?
|
| Bone and Bones | 1 | 2022 | 91 | 0.680 |
Why?
|
| Hip Dislocation | 1 | 2020 | 7 | 0.630 |
Why?
|
| Perineum | 1 | 2020 | 17 | 0.630 |
Why?
|
| Fractures, Comminuted | 1 | 2020 | 11 | 0.630 |
Why?
|
| Surgical Wound Infection | 3 | 2026 | 100 | 0.620 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2020 | 40 | 0.610 |
Why?
|
| Femur Neck | 1 | 2019 | 18 | 0.600 |
Why?
|
| Femur Head | 1 | 2019 | 12 | 0.570 |
Why?
|
| Osteotomy | 1 | 2019 | 54 | 0.570 |
Why?
|
| Sacrum | 1 | 2018 | 18 | 0.560 |
Why?
|
| Pelvis | 2 | 2021 | 67 | 0.540 |
Why?
|
| Tibial Fractures | 2 | 2026 | 31 | 0.510 |
Why?
|
| Femoral Fractures | 3 | 2024 | 44 | 0.490 |
Why?
|
| Humans | 20 | 2026 | 32323 | 0.390 |
Why?
|
| Hip Injuries | 1 | 2013 | 10 | 0.390 |
Why?
|
| Abdominal Injuries | 1 | 2013 | 32 | 0.380 |
Why?
|
| Wounds, Gunshot | 1 | 2013 | 36 | 0.370 |
Why?
|
| Calcaneus | 1 | 2012 | 13 | 0.370 |
Why?
|
| Tendinopathy | 1 | 2012 | 12 | 0.370 |
Why?
|
| Achilles Tendon | 1 | 2012 | 26 | 0.360 |
Why?
|
| Suture Techniques | 1 | 2012 | 60 | 0.360 |
Why?
|
| Periprosthetic Fractures | 2 | 2024 | 8 | 0.360 |
Why?
|
| Radiographic Image Enhancement | 1 | 2008 | 30 | 0.290 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 38 | 0.280 |
Why?
|
| Trauma Centers | 2 | 2026 | 86 | 0.280 |
Why?
|
| Osteomyelitis | 2 | 2020 | 26 | 0.270 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 132 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2025 | 906 | 0.260 |
Why?
|
| Femur | 3 | 2024 | 74 | 0.260 |
Why?
|
| Fracture Fixation | 2 | 2025 | 43 | 0.250 |
Why?
|
| Tobramycin | 1 | 2026 | 2 | 0.240 |
Why?
|
| Vancomycin | 1 | 2026 | 17 | 0.240 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2026 | 41 | 0.240 |
Why?
|
| Adult | 7 | 2026 | 9267 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 2 | 2026 | 336 | 0.230 |
Why?
|
| Bone Plates | 3 | 2024 | 72 | 0.230 |
Why?
|
| Female | 8 | 2026 | 19969 | 0.220 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.210 |
Why?
|
| Iodine | 1 | 2024 | 7 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.210 |
Why?
|
| Chlorhexidine | 1 | 2024 | 8 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.200 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2024 | 20 | 0.200 |
Why?
|
| Retrospective Studies | 4 | 2025 | 3613 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Middle Aged | 6 | 2026 | 11848 | 0.190 |
Why?
|
| Aged | 5 | 2025 | 10259 | 0.180 |
Why?
|
| Temperature | 1 | 2022 | 58 | 0.180 |
Why?
|
| Spinal Injuries | 1 | 2021 | 24 | 0.170 |
Why?
|
| Blast Injuries | 1 | 2021 | 30 | 0.170 |
Why?
|
| Radiography | 2 | 2019 | 358 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 772 | 0.170 |
Why?
|
| Lower Extremity | 1 | 2021 | 99 | 0.160 |
Why?
|
| Male | 6 | 2026 | 19456 | 0.160 |
Why?
|
| Femur Head Necrosis | 1 | 2020 | 11 | 0.160 |
Why?
|
| Acetabulum | 1 | 2009 | 24 | 0.150 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2009 | 38 | 0.150 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2020 | 64 | 0.150 |
Why?
|
| Reoperation | 1 | 2020 | 247 | 0.140 |
Why?
|
| Ilium | 1 | 2018 | 15 | 0.140 |
Why?
|
| Accidents, Traffic | 1 | 2020 | 204 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2007 | 43 | 0.120 |
Why?
|
| Adolescent | 2 | 2025 | 3521 | 0.120 |
Why?
|
| Staphylococcus aureus | 1 | 2007 | 55 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2024 | 3410 | 0.120 |
Why?
|
| Debridement | 1 | 2013 | 45 | 0.100 |
Why?
|
| Physical Examination | 1 | 2013 | 83 | 0.090 |
Why?
|
| Suture Anchors | 1 | 2012 | 13 | 0.090 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 44 | 0.090 |
Why?
|
| Musculoskeletal System | 1 | 2012 | 16 | 0.090 |
Why?
|
| Multiple Trauma | 1 | 2012 | 41 | 0.090 |
Why?
|
| Obesity | 1 | 2009 | 1111 | 0.090 |
Why?
|
| Orthopedics | 1 | 2012 | 91 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 3899 | 0.060 |
Why?
|
| United States | 2 | 2026 | 4079 | 0.060 |
Why?
|
| Powders | 1 | 2026 | 9 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2026 | 293 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2025 | 201 | 0.050 |
Why?
|
| Antisepsis | 1 | 2024 | 3 | 0.050 |
Why?
|
| 2-Propanol | 1 | 2024 | 3 | 0.050 |
Why?
|
| Canada | 1 | 2024 | 64 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 96 | 0.050 |
Why?
|
| Extremities | 1 | 2024 | 51 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2016 | 859 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2024 | 126 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1300 | 0.040 |
Why?
|
| Skin | 1 | 2024 | 213 | 0.040 |
Why?
|
| Laboratories | 1 | 2021 | 18 | 0.040 |
Why?
|
| Explosions | 1 | 2021 | 18 | 0.040 |
Why?
|
| Ethanol | 1 | 2024 | 196 | 0.040 |
Why?
|
| Manikins | 1 | 2021 | 39 | 0.040 |
Why?
|
| Operating Rooms | 1 | 2021 | 41 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2025 | 2319 | 0.040 |
Why?
|
| Medical Records | 1 | 2009 | 75 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 757 | 0.040 |
Why?
|
| Young Adult | 1 | 2025 | 2652 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 38 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2007 | 81 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2238 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2012 | 77 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 89 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2012 | 123 | 0.020 |
Why?
|